Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sonoma Biotherapeutics Awarded ScaleReady G-Rex Grant  | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sonoma Biotherapeutics Awarded ScaleReady G-Rex Grant 

To support development of a G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma
Sonoma Biotherapeutics

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corp. and CellReady, have awarded Sonoma Biotherapeutics a $300,000 G-Rex Grant.  SonomaBio’s G-Rex Grant aims to enable expedited development of a G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for clinical investigation of SonomaBio products in development for various autoimmune related disorders. 

“Regulatory T cells represent a promising new treatment modality, and we are honored to support Sonoma Biotherapeutics’ trailblazing mission to bring these innovative therapies to patients suffering from debilitating autoimmune diseases. The G-Rex Grant is helping SonomaBio transition from open flask-based technology to the proven, commercially viable G-Rex platform—an essential step in preparing their CMC for commercial readiness,” said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex. 

As part of the grant, SonomaBio will explore optimization strategies for their Treg platform process to establish a modular and scalable manufacturing approach using G-Rex. Functionally closing the manufacturing process will be accomplished through the integration of closed system G-Rex devices and, ProPak GMP Cytokines. Moreover, through the G-Rex Grant, SonomaBio will get early access to a variety of innovations coming from Wilson Wolf including integrated process analytic technology (PAT), new closed system tools, and new G-Rex models. 

ScaleReady’s G-Rex Grant Program aims to advance the state of cell and gene-modified cell therapy (CGT) development and manufacturing. G-Rex Grant Recipients also gain access to support from ScaleReady’s growing consortium of G-Rex Grant Partners who bring tools, technologies and expertise in the areas of cGMP manufacturing, quality and regulatory affairs, CGT business operations, and more. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics